BOSTON—Early-stage prostate cancer treated with radiation therapy should begin hormone therapy immediately if their PSA level rises quickly and doubles within six months after treatment; however patients should forego hormones if PSA levels do not rise as quickly, according to research presented Tuesday at the 50th annual meeting of the American Society for Therapeutic Radiology ...

BOSTON—Cancer patients with brain metastases who undergo stereotactic radiosurgery and whole brain radiation have more than double the risk of developing learning and memory problems, compared to those who only have stereotactic radiosurgery, according to a randomized study presented Tuesday at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO).

BOSTON—Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated with hormone therapy before being treated with brachytherapy, compared to men who are treated with brachytherapy alone, according to a large cohort study presented Tuesday at the 50th annual meeting of the American Society for Therapeutic ...

The FDA has sent a warning letter to Covidien’s CEO and President Richard J. Meelia, based on an inspection of its pharmaceutical manufacturing operation Maryland Heights, Mo., that “revealed serious deviations from the good manufacturing practice regulations.”

Hospitals and freestanding cancer centers now have two new reimbursement codes for coding Medicare claims associated with the use of the 4D localization system and implanted beacon transponders from Calypso Medical Technologies.

The AHIC Successor, a public-private entity, has established a board of directors to lead its efforts to accelerate the adoption of an interoperable health information system in the United States.

BOSTON—Due to the fact that pancreatic cancer often reoccurs, treatment options are often limited to chemotherapy, but researchers at Georgetown University in Washington, D.C., are utilizing Accuray’s CyberKnife to see if radiosurgery is a viable treatment option in select patients, according to a presentation delivered Sunday at the 50th annual meeting of the American Society ...

Shimadzu has introduced a new mobile digital radiography system, the MobiteDaRt Evolution, for use in North America.

Lantheus Medical Imaging has entered an agreement to co-promote Bracco’s CardioGen-82, a myocardial perfusion PET imaging agent.

Block Imaging International has formed a strategic partnership with Dicom Solutions and will now carry a new line of medical imaging digital solutions.